AMGEN BIONATION Regenerative Medicine Innovation Challenge

Ontario Industry Updates
Written By Guest User

Applications are now open for the AMGEN BIONATION Regenerative Medicine Innovation Challenge 2020. Early-stage companies developing innovative technologies and programs in the field are encouraged to apply. Specific areas of interest include:

  • Technologies for non-viral cell transfection

  • Gene editing tools to create a universal host for allogeneic cells

  • Tools to measure cell surface markers

  • Closed processing Tools (not significant bottleneck)

BIONATION2020-Apr1-eng-1024x242.jpg
1189958.jpg
Guest User
Previous

ToeFX receives Health Canada approval for clinical trial
Next

Conavi Medical Receives Approval from Japan for Instravascular Imaging System